Autoimmune phenotypes in schizophrenia reveal novel treatment targets.

Abstract excerpt

Typical and atypical antipsychotics are the first-line treatments for schizophrenia, but these classes of drugs are not universally effective, and they can have serious side effects that impact compliance. Antipsychotic drugs generally target the dopamine pathways with some variation. As research of schizophrenia pathophysiology has shifted away from a strictly dopamine-centric focus, the development of new...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antipsychotic Agents
• Share to Autoimmunity
• Share to Drug Therapy, Combination